Search Results - "Bachtıar, Novilia Sjafri"

Evaluating stability of attenuated Sabin and two novel type 2 oral poliovirus vaccines in children by Wahid, Rahnuma, Mercer, Laina, Gast, Chris, De Leon, Tirza, Sáez-Llorens, Xavier, Fix, Alan, Macadam, Andrew, Stephens, Laura, Chumakov, Konstantin, Smits, Saskia L., Murreddu, Marta, Konopka-Anstadt, Jennifer L., Steven Oberste, M., Burns, Cara C., Andino, Raul, Bachtiar, Novilia Sjafri, Tritama, Erman, Bandyopadhyay, Ananda S., Aguirre, Gabriela, Rüttimann, Ricardo, Konz, John O.

“…Novel oral poliovirus vaccine type 2 (nOPV2) is being developed to reduce the rare occurrence of disease and outbreaks associated with the genetic instability…”
Get full text

A randomized controlled trial to evaluate the effect of influenza vaccination and probiotic supplementation on immune response and incidence of influenza-like illness in an elderly population in Indonesia by Koesnoe, Sukamto, Masjkuri, Nuning, Adisasmita, Asri, Djauzi, Samsuridjal, Kartasasmita, Cissy, Sundoro, Julitasari, Nadjib, Mardiati, Korib, Mondastri, Muthia, Alisa Nurul, Muzellina, Virly Nanda, Habibah, Ummu, Nursyirwan, Saskia Aziza, Djaya, Kristoforus Hendra, Bachtiar, Novilia Sjafri, Sari, Rini Mulia

“…To investigate the effect of influenza vaccination with or without probiotic supplementation on the immune response and incidence of influenza-like illness…”
Get full text

Immunogenicity and safety profile of a primary dose of bivalent oral polio vaccine given simultaneously with DTwP-Hb-Hib and inactivated poliovirus vaccine at the 4th visit in Indonesian infants by Fadlyana, Eddy, Dhamayanti, Meita, Tarigan, Rodman, Mulia Sari, Rini, Sjafri Bachtiar, Novilia, Kartasasmita, Cissy B., Rusmil, Kusnandi

“…•Four bOPV doses and 1 IPV dose resulted in high seroprotection for P1, P2, and P3.•Despite only had 1 dose of P2 in IPV, subjects have high seroprotection for…”
Get full text

Six-month follow up of a randomized clinical trial-phase I study in Indonesian adults and children: Safety and immunogenicity of Salmonella typhi polysaccharide-diphtheria toxoid (Vi-DT) conjugate vaccine by Medise, Bernie Endyarni, Soedjatmiko, Soedjatmiko, Rengganis, Iris, Gunardi, Hartono, Sekartini, Rini, Koesno, Sukamto, Satari, Hindra Irawan, Hadinegoro, Sri Rezeki, Yang, Jae Seung, Excler, Jean-Louis, Sahastrabuddhe, Sushant, Puspita, Mita, Sari, Rini Mulia, Bachtiar, Novilia Sjafri

“…There is a high global incidence of typhoid fever, with an annual mortality rate of 200,000 deaths. Typhoid fever also affects younger children, particularly…”
Get full text

Spontaneous reports of vasculitis as an adverse event following immunization: A descriptive analysis across three international databases by Felicetti, Patrizia, Trotta, Francesco, Bonetto, Caterina, Santuccio, Carmela, Brauchli Pernus, Yolanda, Burgner, David, Chandler, Rebecca, Girolomoni, Giampiero, Hadden, Robert D.M, Kochar, Sonali, Kucuku, Merita, Monaco, Giuseppe, Ozen, Seza, Pahud, Barbara, Phuong, Linny, Bachtiar, Novilia Sjafri, Teeba, Amina, Top, Karina, Varricchio, Frederick, Wise, Robert P, Zanoni, Giovanna, Živkovic, Saša, Bonhoeffer, Jan

“…Highlights • Similar results in three database. • Vasculitis was mainly reported in children. • Case definitions would improve data quality and comparability…”
Get full text

A novel Vi-diphtheria toxoid typhoid conjugate vaccine is safe and can induce immunogenicity in healthy Indonesian children 2-11 years: a phase II preliminary report by Medise, Bernie Endyarni, Soedjatmiko, Soedjatmiko, Gunardi, Hartono, Sekartini, Rini, Satari, Hindra Irawan, Hadinegoro, Sri Rezeki, Wirahmadi, Angga, Puspita, Mita, Sari, Rini Mulia, Yang, Jae Seung, Sil, Arijit, Sahastrabuddhe, Sushant, Bachtiar, Novilia Sjafri

“…Typhoid fever caused by Salmonella enteric serovar Typhi (S. Typhi) is a common cause of morbidity in the world. In 2017, 14.3 million cases of Typhoid and…”
Get full text

One-month follow up of a randomized clinical trial-phase II study in 6 to <24 months old Indonesian subjects: Safety and immunogenicity of Vi-DT Typhoid Conjugate Vaccine by Medise, Bernie Endyarni, Soedjatmiko, Soedjatmiko, Gunardi, Hartono, Sekartini, Rini, Satari, Hindra Irawan, Hadinegoro, Sri Rezeki, Wirahmadi, Angga, Puspita, Mita, Sari, Rini Mulia, Yang, Jae Seung, Sil, Arijit, Sahastrabuddhe, Sushant, Bachtiar, Novilia Sjafri

“…•Typhoid Vi-DT conjugate vaccine has been proven to be safe and immunogenic in children under 2 years.•The most common local reaction found in Typhoid Vi-DT…”
Get full text

Genotype profiles of rotavirus strains in children under 5-year-old outpatients with diarrhea in Bandung, West Java, Indonesia by Prasetyo, Dwi, Ermaya, Yudith, Sabaroedin, Iesje, Widhiastuti, Dyah, Bachtiar, Novilia, Kartasasmita, Cissy

“…Introduction: Diarrhea is a global leading cause of morbidity and mortality among children under five, with rotaviruses being the most common cause. This study…”
Get full text

A phase II clinical trial of a Vi-DT typhoid conjugate vaccine in healthy Indonesian adolescents and adults: one-month evaluation of safety and immunogenicity by Koesnoe, Sukamto, Medise, Bernie Endyarni, Rengganis, Iris, Hadinegoro, Sri Rezeki, Puspita, Mita, Sari, Rini Mulia, Yang, Jae Seung, Sahastrabuddhe, Sushant, Soedjatmiko, Gunardi, Hartono, Sekartini, Rini, Wirahmadi, Angga, Kekalih, Aria, Mukhi, Sreshta, Satari, Hindra Irawan, Bachtiar, Novilia Sjafri

“…Typhoid fever is commonly found until today, especially in developing countries. It has fatal complications and measures must be taken to reduce the incidence…”
Get full text

DTwP-HB-Hib: antibody persistence after a primary series, immune response and safety after a booster dose in children 18-24 months old by Gunardi, Hartono, Rusmil, Kusnandi, Fadlyana, Eddy, Soedjatmiko, Dhamayanti, Meita, Sekartini, Rini, Tarigan, Rodman, Satari, Hindra Irawan, Medise, Bernie Endyarni, Sari, Rini Mulia, Bachtiar, Novilia Sjafri, Kartasasmita, Cissy B, Hadinegoro, Sri Rezeki S

“…The new combination of DTwP-HB-Hib vaccines has been developed in Indonesia following World Health Organization (WHO) recommendation and integrated into…”
Get full text

Protectivity and safety following recombinant hepatitis B vaccine with different source of bulk compared to hepatitis B (Bio Farma) vaccine in Indonesia by Nency, Yetty M, Rahmadi, Farid Agung, Mulyono, Anantyo, Dimas Tri, Farhanah, Nur, Hapsari, Rebriarina, Farida, Helmia, Sadhana, Udadi, Djagat, Herry, Kristina, Tri Nur, Juniarto, Achmad Zulfa, Puspita, Mita, Sari, Rini Mulia, Bachtiar, Novilia Sjafri

“…Indonesia, a high populous and the second-highest country in epidemicity of hepatitis B in South-East Asia require maintaining its capacity of monovalent…”
Get full text

The immunogenicity, safety, and consistency of an Indonesia combined DTP-HB-Hib vaccine in expanded program on immunization schedule by Rusmil, Kusnandi, Gunardi, Hartono, Fadlyana, Eddy, Soedjatmiko, Dhamayanti, Meita, Sekartini, Rini, Satari, Hindra Irawan, Risan, Nelly Amalia, Prasetio, Dwi, Tarigan, Rodman, Garheni, Reni, Milanti, Mia, Hadinegoro, Sri Rezeki, Tanuwidjaja, Suganda, Bachtiar, Novilia Sjafri, Sari, Rini Mulia

“…WHO recommended incorporation of Haemophilus influenzae type b (Hib) vaccination into immunization program. Indonesia would adopt Hib as a National…”
Get full text

The immunogenicity and safety of the new, Indonesian DTwP-HB-Hib vaccine compared to the DTwP/HB vaccine given with the Hib vaccine by Bachtiar, Novilia Sjafri, Rusmil, Kusnandi, Sudigdoadi, Sunarjati, Kartasasmita, Cissy B, Hadyana, Hadyana

“…Background Haemophilus influenzae type b (Hib) causes infection with predominant manifestations of pneumonia, meningitis, and other invasive diseases,…”
Get full text

The quantity and quality of anti-PRP induced by the new Indonesian DTwP-HB-Hib vaccine compared to the Hib vaccine given with the DTwP-HB vaccine by Bachtiar, Novilia Sjafri, Rusmil, Kusnandi, Sudigdoadi, Sunarjati, Sukandar, Hadyana, Sari, Rini Mulia, Kartasasmita, Cissy B.

“…Background A phase II study of DTwP-HB-Hib vaccine compared to Hib (monovalent) vaccine given simultaneously with DTwP-HB vaccine has been done following the…”
Get full text

Protektivitas, Reaksi Lokal dan Sistemik Pascaimunisasi dengan Vaksin Campak (Bio Farma) dari Bets Vaksin yang Berbeda pada Anak Sekolah Dasar di Sumatera Barat by Julitasari Sundoro, Novilia Sjafri Bachtiar, Syafriyal, Rini Mulia Sari

“…Post Marketing Surveillance should be conducted periodically to monitor whether the quality of marketed products is still favorable. The objectives of this…”
Get full text

Profil Keamanan setelah Pemberian Dosis Primer Vaksin Pentabio® pada Bayi di Indonesia by Julitasari Sundoro, Kusnandi Rusmil, Mei Neni Sitaresmi, Arhana, I.G.G. Djelantik, Sri Rezeki Hadinegoro, Hindra Irawan Satari, Syafriyal, Novilia Sjafri Bachtiar, Rini Mulia Sari

“…Vaksin Hib mulai digunakan pada Pogram Imunisasi Nasional sejak tahun 2013 secara bertahap dan di seluruh Indonesia mulai tahun 2014 dalam bentuk vaksin…”
Get full text

Safety and immunogenicity of the DTP/HB /Hib combination vaccine: phase I study by Rusmil, Kusnandi, Fadlyana, Eddy, Bachtiar, Novilia Sjafri, Hadyana, Hadyana

“…Background The World Health Organization (WHO) hasrecommended the introduction ofhepatitis B (HB) and Haemophilusinfluenza type b (Hib) vaccines into routine…”
Get full text

Titer IgG Pertusis pada Usia Remaja, Dewasa, dan Orang Tua Mempergunakan Metode ELISA dan Mikroaglutinasi Pertusis by Novilia Sjafri Bachtiar, Sadeli Masria, Usep Abdullah Husin

“…Pertussis antigen which only given in primary immunization, could not protect for a long period. In some countries whooping cough became an reemerging disease…”
Get full text

Immunogenicity and safety of a trivalent inactivated influenza vaccine by Fadlyana, Eddy, Rusmil, Kusnandi, Bachtiar, Novilia Sjafri, Gunadi, Rachmat, Sukandar, Hadyana

“…Background Trivalent inactivated influenza vaccines (TIV) containing antigens of two influenza A strains, A(H1N1) and A(H3N2), and one influenza B strain, are…”
Get full text

A phase III, observer-blind, randomized, placebo-controlled study of the efficacy, safety, and immunogenicity of SARS-CoV-2 inactivated vaccine in healthy adults aged 18–59 years: An interim analysis in Indonesia by Fadlyana, Eddy, Rusmil, Kusnandi, Tarigan, Rodman, Rahmadi, Andri Reza, Prodjosoewojo, Susantina, Sofiatin, Yulia, Khrisna, Citra V., Sari, Rini Mulia, Setyaningsih, Lilis, Surachman, Fikrianti, Bachtiar, Novilia Sjafri, Sukandar, Hadyana, Megantara, Imam, Murad, Chrysanti, Pangesti, Krisna Nur A., Setiawaty, Vivi, Sudigdoadi, Sunarjati, Hu, Yaling, Gao, Qiang, Kartasasmita, Cissy B.

“…•Most of the adverse reactions were mild in severity with pain at the injection site as the most frequently reported symptom.•The inactivated SARS-CoV-2…”
Get full text